Impact of Incentives and Information on Quality and Utilization in Primary Care 2014, Baseline Survey
Philippines, 2014
Get MicrodataCreated on
Dec 05, 2022
Last modified
Dec 05, 2022
Page views
62035
Downloads
984
Others [Probing Yes] (C7_4_ProbYes)
Data file: E05_noID
Overview
Valid:
12
Invalid:
0
Type:
Discrete
Start:
2588
End:
2619
Width:
32
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| Alpha 1, Glucose Inhibitors | 1 |
8.3%
|
|
| Combination of Drugs | 1 |
8.3%
|
|
| Glimeperide, DPP4 (Janovia) | 1 |
8.3%
|
|
| Insulin | 4 |
33.3%
|
|
| Lifestyle modification, insulin | 1 |
8.3%
|
|
| Losartan, Simvastatin | 1 |
8.3%
|
|
| Piolitazone, Jianuvia, Sitagliph | 1 |
8.3%
|
|
| Sulfonylurea | 1 |
8.3%
|
|
| Zitagliptine | 1 |
8.3%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.